Abstract: The present invention relates to an immunostimulant and to the use of an immunostimulant in the form of a cross-linked muramyl dipeptide microparticle in the treatment of radiation exposure, radiation poisoning, and mitigating the toxic effects of radiotherapy.
Type:
Grant
Filed:
September 30, 2009
Date of Patent:
March 19, 2019
Assignee:
Innate Immunotherapeutics Limited
Inventors:
Frank B. Gelder, Gillian Alison Webster
Abstract: The present invention is concerned with immunostimulant compositions, in particular compositions comprising microparticulate form of muramyl dipeptide, and their use in the treatment of neoplastic disease.
Type:
Grant
Filed:
August 15, 2016
Date of Patent:
April 24, 2018
Assignee:
Innate Immunotherapeutics Limited
Inventors:
Frank B. Gelder, Gillian Alison Webster
Abstract: The present invention is concerned with immunostimulant compositions, in particular compositions comprising microparticulate form of murmyl dipeptide, and their use in the treatment of neoplastic disease.
Abstract: Disclosed are novel compositions and methods for the treatment of Multiple Sclerosis (MS), and in particular immunostimulatory compositions comprising muramyl dipeptide microparticles for use, e.g., in the treatment of MS.
Type:
Grant
Filed:
December 16, 2009
Date of Patent:
March 5, 2013
Assignee:
Innate Immunotherapeutics Limited
Inventors:
Frank B. Gelder, Gillian Alison Webster
© 2024 Justia
